The Spring 2012 season of CACAO has started!
HUMAN:APOM
Contents |
| Species (Taxon ID) | Homo sapiens (Human). (taxon:9606) | |
| Gene Name(s) | APOM ( synonyms: G3A, NG20 ) | |
| Protein Name(s) |
| |
| External Links | ||
| UniProt Identifier | APOM_HUMAN | |
| UniProt Accessions | O95445, B0UX98, Q9P046, Q9UMP6, | |
| EMBL | AF118393, AJ245434, AF161454, AF129756, BA000025, AL662801, AL670886, AL805934, BX511262, CR753842, CR354443, CR759761, CH471081, BC020683, | |
| RefSeq | NP_061974.2, | |
| PDB | 2WEW, 2WEX, 2YG2, | |
| IntAct | O95445, | |
| Ensembl | ENST00000375916, ENST00000383438, ENST00000426800, ENST00000430282, ENST00000432598, ENST00000436931, ENST00000441436, | |
| Pfam | PF11032, | |
Annotations
| Qualifier | GO ID | GO term name | Reference | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0034364 |
high-density lipoprotein particle |
IEA |
C |
Source: UniProtKB-KW |
||||
| GO:0005887 |
integral to plasma membrane |
TAS: Traceable Author Statement |
C |
Source: ProtInc |
||||
| GO:0005319 |
lipid transporter activity |
TAS: Traceable Author Statement |
F |
Source: ProtInc |
||||
| GO:0042632 |
cholesterol homeostasis |
IC: Inferred by Curator |
P |
Source: UniProtKB |
required field missing | |||
| GO:0043691 |
reverse cholesterol transport |
ISS: Inferred from Sequence or Structural Similarity |
P |
Source: UniProtKB |
required field missing | |||
| GO:0033344 |
cholesterol efflux |
IMP: Inferred from Mutant Phenotype |
P |
Source: UniProtKB |
required field missing | |||
| GO:0034375 |
high-density lipoprotein particle remodeling |
IMP: Inferred from Mutant Phenotype |
P |
Source: UniProtKB |
required field missing | |||
| GO:0034380 |
high-density lipoprotein particle assembly |
ISS: Inferred from Sequence or Structural Similarity |
P |
Source: UniProtKB |
required field missing | |||
| GO:0034384 |
high-density lipoprotein particle clearance |
ISS: Inferred from Sequence or Structural Similarity |
P |
Source: UniProtKB |
required field missing | |||
| GO:0005319 |
lipid transporter activity |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0005488 |
binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0005576 |
extracellular region |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005576 |
extracellular region |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0243 |
C |
||||
| GO:0005615 |
extracellular space |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSRNOP00000001126 |
C |
||||
| GO:0005887 |
integral to plasma membrane |
TAS: Traceable Author Statement |
C |
|||||
| GO:0006810 |
transport |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006869 |
lipid transport |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0009749 |
response to glucose stimulus |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSRNOP00000001126 |
P |
||||
| GO:0033344 |
cholesterol efflux |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0033344 |
cholesterol efflux |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0034361 |
very-low-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034362 |
low-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034364 |
high-density lipoprotein particle |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0034365 |
discoidal high-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034366 |
spherical high-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034375 |
high-density lipoprotein particle remodeling |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0034380 |
high-density lipoprotein particle assembly |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0034384 |
high-density lipoprotein particle clearance |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0034445 |
negative regulation of plasma lipoprotein particle oxidation |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0042632 |
cholesterol homeostasis |
IC: Inferred by Curator |
GO:0033344 |
P |
||||
| GO:0043691 |
reverse cholesterol transport |
ISS: Inferred from Sequence or Structural Similarity |
P |
| ||||
| edit table |
Notes
References
See Help:References for how to manage references in GONUTS.
- ↑ 1.0 1.1 1.2 1.3 1.4 Christoffersen C et al. (2006) Isolation and characterization of human apolipoprotein M-containing lipoproteins. J Lipid Res 47: 1833-43 PubMed GONUTS page
- ↑ Xu N & Dahlbäck B (1999) A novel human apolipoprotein (apoM). J Biol Chem 274: 31286-90 PubMed GONUTS page
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Wolfrum C et al. (2005) Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11: 418-22 PubMed GONUTS page
- ↑ Mancone C et al. (2007) Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF. Proteomics 7: 143-54 PubMed GONUTS page
- ↑ Christoffersen C et al. (2008) Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J Biol Chem 283: 1839-47 PubMed GONUTS page